Eli Lilly reported dysesthesia was "generally mild" and "rarely led to discontinuation." TRIUMPH-1 the larger general obesity trial with 2,339 patients at 80 weeks confirmed dysesthesia at 12.5% on the 12mg dose, substantially lower than TRIUMPH-4's 20.9%
Nature Made has a convenient GLP-1 Companion Health Pack, which provides scientifically formulated nutritional support for people on weight-loss diets
Even the maximum 15 mg dose only requires 0.75 ml, or 75 units
So, in sort of the bariatric endoscopy and bariatric surgery realm, we advocate for more of a combined approach. That could include bariatric surgery or endoscopy followed by a short course of GLP-1 medications
Starting at the left SARS-CoV-2 binds to the ACE2 receptors on cell membranes, decreasing ACE2 activity That cause an increase in Angiotensin 2 and a decrease in Angiotensin 1 and 7 That increases Hydroxy Radical (OH ) That causes endothelial cell dysfunction (affecting the cells lining the blood vessels) That triggers an increase in Von Willebrands Factor (vWF), released when there is damage to the endothelium Which then causes thrombosis (clotting) Recent autopsies of lungs from people that have died of COVID-19 have found that the small vessels are full of these clots, reducing blood flow and preventing oxygenation of the blood